Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sammy Eghbalieh

Vascular Surgery Porter Ranch, CA Medical Doctor

NPI 1275794224 CMS profile 1347277

19950 Rinaldi St # 101D, Porter Ranch, CA 91326

Open in the dashboard

General payments

$207,137

829 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sammy Eghbalieh of Porter Ranch, CA is reported in the CMS Open Payments database as having received $207,137 across 829 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,907 147
2024 General $32,277 151
2023 General $42,841 106
2022 General $36,847 137
2021 General $25,350 114
2020 General $24,516 69
2019 General $14,400 105

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sammy Eghbalieh
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Sammy Eghbalieh were reported at $30,907. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Sammy Eghbalieh Vascular Surgery median Middle half National median
2019 $14,400 $796 $226–$2,363 $163
2020 $24,516 $348 $118–$1,110 $114
2021 $25,350 $471 $158–$1,421 $132
2022 $36,847 $725 $222–$2,183 $149
2023 $42,841 $836 $257–$2,440 $160
2024 $32,277 $909 $252–$2,619 $164
2025 $30,907 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $48,353 141 payments
  2. Terumo Medical Corporation $25,168 36 payments
  3. Silk Road Medical, Inc. $23,971 63 payments
  4. Acell, Inc. $23,263 28 payments
  5. Boston Scientific Corporation $19,148 129 payments
  6. Shockwave Medical, Inc $15,609 35 payments
  7. Siemens Medical Solutions USA, Inc. $12,428 28 payments
  8. Penumbra, Inc. $9,060 30 payments
  9. W. L. Gore & Associates, Inc. $4,811 47 payments
  10. Stryker Corporation $1,991 15 payments
  11. Other $23,336 277 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $52,212 685 payments
  2. Consulting Fee $43,188 19 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,645 19 payments
  4. Travel and Lodging $29,219 79 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $20,500 7 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $19,300 5 payments
  7. Education $74 15 payments
Products named General payments · program years 2019–2025
  1. ENDURANT IIS $43,658 95 payments
  2. ENROUTE Transcarotid Stent $23,971 63 payments
  3. ENROUTE Transcarotid Neuroprotection System $23,971 63 payments
  4. Azur CX Detachable $23,967 18 payments
  5. GLIDESHEATH SLENDER $23,400 14 payments
  6. HydroPearl $23,224 12 payments
  7. NAVICROSS $23,217 12 payments
  8. GLIDEWIRE $23,200 11 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $14,624 25 payments
  10. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $9,640 11 payments
  11. Other $81,516 723 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 154 billing codes

Paid by Medicare

$1,488,212

Of which drugs: $727,864

Medicare patients

1,156

Average age 74

Services billed

9,957

578 women, 578 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 64%
Arthritis 62%
Ischemic heart disease 59%
Chronic kidney disease 58%
Heart failure 51%
Depression 35%
Atrial fibrillation 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 55 3,030 $281

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
$28 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

829 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record